Print Page   |   Sign In   |   Register
Companies: Oncolytics Biotech, Inc. (ONCYF)

Company Profile

Description

Oncolytics Biotech Inc., a development stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancers. The company develops REOLYSIN, a therapeutic reovirus that is in various clinical trials for use as human cancer therapeutic. Its cancer product is a potential therapeutic for tumors possessing an activated Ras pathway. Oncolytics Biotech Inc. was founded in 1998 and is headquartered in Calgary, Canada.

Company Officers/Contacts

Dr. Bradley G. Thompson Ph.D. - Exec. Chairman, Chief Exec. Officer and Pres
Mr. Kirk J. Look CA - Chief Financial Officer
Dr. Matthew C. Coffey Ph.D. - Chief Operating Officer and Director
Dr. George M. Gill M.D. - Chief Safety Officer and Sr. VP of Regulatory Affairs
Dr. Alan J. Tuchman M.D., MBA(FAAN) - Chief Medical Officer and Sr. VP of Medical & Clinical Affairs

Contact Information

1167 Kensington Crescent, NW
Suite 210
Calgary, AB T2N 1X7
Canada

Financial Reporting/Disclosure

Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Dec 31, 2015 20-F
CIK 0001129928
Fiscal Year End 12/31
OTC Marketplace OTCQX International

Profile Data

SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: Canada
Year of Inc. Not Available
Employees 22 a/o Dec 31, 2014

Service Providers

OTCQX Advisor
Dorsey & Whitney LLP
1400 Wewatta Street
Suite 400
Denver, CO, 80202
USA

Accounting/Auditing Firm
Ernst & Young LLP
440 2 Ave SW
1000
Calgary, ALB, T2P 5E9
Canada

Legal Counsel
McCarthy Tetrault LLP
Suite 3300
421 7th Ave SW
Calgary, ALB, T2P 4K9
Canada

Investor Relations Firm
National Equicom
800 - 6 Avenue SW
Calgary, ALB, T2P 3G3
Canada

 

Community Search
Sign In